Ferronova and Purdue Research Foundation (PRF) sign licensing agreement for use of Fibroblast Activation Protein (FAP) inhibitor in radiotherapy
by Uniseed01 | Aug 23, 2023 | Latest News
Recent Posts
- Uniseed invests in solar farm management technology to make solar farms more efficient
- Baker Heart and Diabetes Institute study shows potential of Cardihab technology for cardiac rehabilitation
- New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance
- ENA Respiratory Expands Leadership Team and Extends U.S. Department of Defense Funding to Enable Phase II Program of INNA-051 in Community-Acquired Viral Respiratory Infections
- Ferronova and Purdue Research Foundation (PRF) sign licensing agreement for use of Fibroblast Activation Protein (FAP) inhibitor in radiotherapy
Archives
- September 2023
- August 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- November 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- March 2022
- February 2022
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- June 2017
- May 2017
- March 2017
- February 2017
- September 2016
- April 2016
- December 2015
- September 2015
- July 2015
- June 2015
- May 2015
- March 2015
- February 2015
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
Recent Comments